HomeALZN • NASDAQ
add
Alzamend Neuro Inc
Previous close
$1.71
Year range
$1.40 - $38.97
Market cap
6.65M USD
Avg Volume
3.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jul 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 962.40K | -72.70% |
Net income | -974.41K | 72.38% |
Net profit margin | — | — |
Earnings per share | -1.25 | 79.17% |
EBITDA | -949.72K | 72.97% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jul 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.19M | -29.58% |
Total assets | 1.67M | -36.46% |
Total liabilities | 2.88M | 5.15% |
Total equity | -1.21M | — |
Shares outstanding | 3.89M | — |
Price to book | -1.21 | — |
Return on assets | -209.09% | — |
Return on capital | 137.26% | — |
Cash Flow
Net change in cash
| (USD) | Jul 2024info | Y/Y change |
|---|---|---|
Net income | -974.41K | 72.38% |
Cash from operations | -1.06M | 67.99% |
Cash from investing | -90.00K | 38.88% |
Cash from financing | 1.96M | — |
Net change in cash | 817.90K | 123.74% |
Free cash flow | -790.98K | 62.73% |
About
Founded
2016
Headquarters
Website
Employees
6
